Company Profile
Masimo Stock Price, News & Analysis
- Ticker:
- MASI
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
178.78 USD (+0.03%)
Close
Last updated: June 3, 2026
9.36B USD
Market cap
Why the stock is moving
Current closing-price context is not available for MASI.
Company overview
Business overview
Masimo is a medical technology company focused on noninvasive monitoring, pulse oximetry, and connected healthcare devices. Its products are used in hospitals and consumer health settings for real-time patient monitoring.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Masimo has a global footprint in patient monitoring and consumer health. It sits in medtech rather than biotechnology.
Business Model Characteristics
The company earns revenue through monitoring devices, consumables, and connected-health solutions. Investors follow product adoption, reimbursement, hospital penetration, and the role of consumer-health assets in the overall story.
Position Within the Biotechnology Landscape
Masimo sits outside biotech but within the healthcare innovation stack. Its stock is driven by device adoption, technology execution, and litigation or strategic issues more than by drug events.
Future catalysts
Masimo’s catalysts are hospital-monitoring adoption, consumer-health recovery, and continued rollout of the connected monitoring platform. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Masimo (MASI)?
Masimo (MASI) most recently closed at 178.78 USD, a +0.03% move versus the previous session.
What is the market cap of Masimo (MASI)?
Masimo currently has a market capitalization of 9.36B USD on BioPharmSignal.
What does Masimo do?
Masimo is a medical technology company focused on noninvasive monitoring, pulse oximetry, and connected healthcare devices. Its products are used in hospitals and consumer health settings for real-time patient monitoring.
On which exchange is MASI stock listed?
Masimo (MASI) is associated with NASDAQ, United States, Biopharma.
What is Masimo?
Masimo’s catalysts are hospital-monitoring adoption, consumer-health recovery, and continued rollout of the connected monitoring platform.
Which conditions is Masimo targeting with Masimo?
Masimo’s catalysts are hospital-monitoring adoption, consumer-health recovery, and continued rollout of the connected monitoring platform.
How does Masimo describe recent progress with Masimo?
Masimo’s catalysts are hospital-monitoring adoption, consumer-health recovery, and continued rollout of the connected monitoring platform.
What future catalysts are investors watching for Masimo?
Masimo’s catalysts are hospital-monitoring adoption, consumer-health recovery, and continued rollout of the connected monitoring platform. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers...